(19)
(11)
EP 0 835 319 A1
(12)
(43)
Date of publication:
15.04.1998
Bulletin 1998/16
(21)
Application number:
96921006.0
(22)
Date of filing:
28.06.1996
(51)
International Patent Classification (IPC):
C12N
15/
09
( . )
A61K
35/
76
( . )
A61K
48/
00
( . )
C07K
14/
47
( . )
C07K
19/
00
( . )
C12N
15/
12
( . )
A61K
31/
70
( . )
A61K
38/
00
( . )
A61P
35/
00
( . )
C07K
14/
82
( . )
C12N
5/
10
( . )
C12N
15/
83
( . )
(86)
International application number:
PCT/GB1996/001560
(87)
International publication number:
WO 1997/002354
(
23.01.1997
Gazette 1997/05)
(84)
Designated Contracting States:
AT BE CH DE DK FR GB IT LI NL SE
(30)
Priority:
30.06.1995
GB 19950013342
(71)
Applicant:
MEDICAL RESEARCH COUNCIL
London W1N 4AL (GB)
(72)
Inventor:
LaTHANGUE, Nicholas, Barrie University of Glasgow
Davidson Bldg. Glasgow G12 8QQ (GB)
(74)
Representative:
Brasnett, Adrian Hugh, et al
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)
(54)
INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1